The T cell activation marker CD150 can be used to identify alloantigen-activated CD4+25+ regulatory T cells

被引:15
作者
Browning, MB [1 ]
Woodliff, JE
Konkol, MC
Pati, NT
Ghosh, S
Truitt, RL
Johnson, BD
机构
[1] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[2] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA
关键词
CD4(+)25(+) cells; CD150; human regulatory T cells; graft vs. host disease;
D O I
10.1016/j.cellimm.2004.03.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have been investigating whether alloantigen-specific CD4(+)25(+) regulatory T cells can be identified for use in treating graft-versus-host disease. CD 150, which is upregulated on the surface of all activated T lymphocytes, was identified as a candidate marker for alloantigen-activated CD4(+)25(+) regulatory T cells by gene chip analysis. Freshly isolated CD4(+)25(+) cells had only low cell-surface expression of CD150. comparable to that of CD4(+)25(-) T cells. Increased CD150 expression was observed on all T cells after coculture with allogeneic stimulator cells. When Purified CD4(+)25(+) cells were precultured with allogeneic stimulator cells, then sorted into CD150(+) and CD150(-) subsets, allosuppressive activity was contained primarily in the CD150(+) fraction. These cells also suppressed the proliferation of alloantigen-activated autologous T cells, and they could be expanded in vitro without loss of their suppressive capacity. These results suggest that CD150 can be used as a marker for the identification of purified alloantigen-activated CD4(+)25(+) regulatory T cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 41 条
[21]   Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients [J].
Morra, M ;
Simarro-Grande, M ;
Martin, M ;
Chen, ASI ;
Lanyi, A ;
Silander, O ;
Calpe, S ;
Davis, J ;
Pawson, T ;
Eck, MJ ;
Sumegi, J ;
Engel, P ;
Li, SC ;
Terhorst, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (39) :36809-36816
[22]   Human CD4+CD25+ cells:: a naturally occurring population of regulatory T cells [J].
Ng, WF ;
Duggan, PJ ;
Ponchel, F ;
Matarese, G ;
Lombardi, G ;
Edwards, AD ;
Isaacs, JD ;
Lechler, RI .
BLOOD, 2001, 98 (09) :2736-2744
[23]  
Onizuka S, 1999, CANCER RES, V59, P3128
[24]   Regulatory CD4 T cells:: expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency [J].
Papiernik, M ;
de Moraes, ML ;
Pontoux, C ;
Vasseur, F ;
Pénit, C .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (04) :371-378
[25]   Natural CD4+ CD25+ regulatory T cells.: Their role in the control of superantigen responses [J].
Papiernik, M .
IMMUNOLOGICAL REVIEWS, 2001, 182 :180-189
[26]   Difference in gene expression profiles between human CD4+CD25+ and CD4+CD25- T cells [J].
Pati, N ;
Ghosh, S ;
Hessner, MJ ;
Khoo, HJ ;
Wang, XJ .
IMMUNOLOGY OF DIABETES II: PATHOGENESIS FROM MOUSE TO MAN, 2003, 1005 :279-283
[27]  
SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151
[28]   B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes [J].
Salomon, B ;
Lenschow, DJ ;
Rhee, L ;
Ashourian, N ;
Singh, B ;
Sharpe, A ;
Bluestone, JA .
IMMUNITY, 2000, 12 (04) :431-440
[29]   Certified professionals:: CD4+CD25+ suppressor T cells [J].
Shevach, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :F41-F45
[30]  
Shimizu J, 1999, J IMMUNOL, V163, P5211